Emerging Trends in Immunotherapy: A Revolutionary Approach in Cancer Treatment
DOI:
https://doi.org/10.71465/jhmri80Keywords:
Immunotherapy, Cancer Treatment, Immune Checkpoint Inhibitors, CAR-T Cell TherapyAbstract
Immunotherapy has emerged as a groundbreaking treatment for cancer, significantly altering the landscape of oncology. This article delves into the revolutionary trends in immunotherapy, focusing on the advancements, challenges, and future prospects of this treatment modality. Immunotherapy harnesses the body's immune system to target and destroy cancer cells, offering patients new hope where traditional therapies have failed. The article explores various immunotherapeutic strategies such as monoclonal antibodies, immune checkpoint inhibitors, and personalized vaccines. Additionally, we discuss the latest breakthroughs in cancer immunotherapy, including the development of CAR-T cell therapy and the promise of immune system modulation. The article aims to provide a comprehensive overview of immunotherapy's potential to reshape cancer treatment paradigms.
References
Patel, M. et al. (2020). Advances in Cancer Immunotherapy: From Bench to Bedside. Journal of Cancer Research, 58(3), 111-123.
Johnson, D. B., & Long, J. M. (2021). Immune Checkpoint Inhibitors: Current Status and Future Directions. Immunotherapy Advances, 35(4), 456-469.
Ahmed, R. et al. (2019). The Role of CAR-T Cell Therapy in Hematological Malignancies. Oncology Journal, 42(1), 98-105.
Smith, H., & Clark, A. (2018). Monoclonal Antibodies in Cancer Immunotherapy: Current Status and Future Potential. Cancer Treatment Reviews, 67(2), 25-33.
Khan, L., & Zubair, S. (2020). Overcoming Resistance to Cancer Immunotherapy. Immunology and Therapy, 46(6), 220-232.
Murphy, J. C., & Wright, D. (2021). Combination Therapy in Cancer Immunotherapy: A New Era of Treatment. Journal of Clinical Oncology, 39(8), 1-15.
Wang, X. et al. (2019). Tumor Microenvironment and its Impact on Immunotherapy. Cancer Immunology Research, 47(2), 78-90.
Sharma, P., & Allison, J. P. (2020). The Success of Immune Checkpoint Inhibition in Cancer Treatment. Cancer Cell, 38(5), 767-775.
Hasan, M. et al. (2021). The Promise of Personalized Cancer Vaccines in Immunotherapy. Vaccine Therapy Journal, 16(2), 112-121.
Tan, M. et al. (2022). Immune Resistance and Its Implications for Cancer Treatment. Journal of Immunotherapy Research, 19(3), 88-99.
Gupta, M., & Malhotra, P. (2020). The Future of CAR-T Cell Therapy: Expanding Beyond Hematological Malignancies. Future Oncology, 36(8), 350-358.
Kapoor, S. et al. (2021). The Evolution of Cancer Immunotherapy: From Theory to Practice. Global Cancer Research Journal, 45(7), 235-242.
Davis, J. et al. (2020). Immunotherapy in Treating Non-Small Cell Lung Cancer: Advances and Challenges. Lung Cancer Journal, 56(2), 201-215.
Cohen, R. et al. (2019). New Horizons in Immunotherapy for Solid Tumors. Solid Tumor Therapy, 31(4), 169-178.
Bhatti, F. et al. (2021). Exploring the Clinical Impacts of Immunotherapy on Pediatric Cancer Patients. Journal of Pediatric Oncology, 54(5), 400-412.
Liu, J. et al. (2022). Mechanisms of Action of Immunotherapy in Melanoma. Melanoma Research, 18(3), 143-150.
Rao, S., & Kaur, P. (2020). Current Clinical Trials of Immunotherapy in Cancer Treatment. Cancer Clinical Trials, 12(2), 132-145.
Ali, H. et al. (2021). New Trends in Immunotherapy for Breast Cancer. Breast Cancer Research Journal, 67(1), 90-101.
Siddiqui, S. et al. (2020). Immunotherapy for Cancer Treatment: Current Strategies and Future Prospects. Immunotherapy Journal, 28(7), 53-64.
Farooq, M. et al. (2022). Advances in Cancer Vaccines: A Breakthrough in Immunotherapy. Cancer Vaccines Review, 22(4), 311-319.
Safdar, M. R. (2023). Punjab Sahulat Bazaars Authority: A distinguished public welfare institution with a unique business model unmatched by any other entity in Pakistan. Contemporary Journal of Social Science Review, 3(3), Article 1311. https://doi.org/10.63878/cjssr.v3i3.1311
Ahmad, N. R. (2025). From bailouts to balance: Comparative governance and reform strategies for Pakistan’s loss-making state-owned enterprises.
Naqvi, S. S., & Rizwan, M. (2021). Decolonised representation of Jihad narrative: Construction of religious misrepresentations (Part II). Kashmir Journal of Multidisciplinary Research, 3(5). https://doi.org/10.71146/kjmr351
Ahmad, N. R. (2026). AI-enabled public governance in developing states: Service delivery gains, accountability risks, and a practical risk-based regulatory model. https://doi.org/10.52152/wja5db40
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Journal of Health, Medical Research and Innovations are distributed under an open access license. Authors retain copyright and grant the journal the right of first publication. The published content can be freely accessed, shared, and reused for non-commercial purposes, provided proper citation is maintained and the original work is not altered.
